Main Article Content
Session Description: Today’s healthcare industry is unapologetically data-driven. From virtual biotech start-ups to big pharma and independent research agencies, making data available to the public, whether positive or negative, is an integral component of any research and development effort. Among all the means available for scientific communications, peer-reviewed publications remain the gold standard platform for the public release and vetting of biomedical data, from preclinical to advanced-stage clinical studies. And behind most effective peer-review communication strategies and efforts, there is craft, knowledge and a mix of experience, intuition and resourcefulness.
Our session will focus on the rules and norms shaping the peer-review publication ecosystem, discussing best practices and industry guidance, providing you with a comprehensive understanding of the approach, the standards, the development, and ultimately the publication, of biomedical manuscripts. Topics to be covered include: conceptualization: how different types of studies make it into manuscripts; steps to publication; industry guidance and authorship criteria: GPP3 and ICMJE; defining manuscripts: whitepaper vs peer-review publication vs editorial; journal selection; and management of the peer-review process.
As publications professionals in the pharmaceutical industry, we have provided strategic and executional support to clients around the world. Our goal is always the same: to excel as publication partners, from concept to print. We look forward to seeing you on October 24, 2018, for an informative and insightful session on best practices in peer-review publications.
Authors retain copyright of their work, with first publication rights granted to Telehealth and Medicine Today (TMT).